Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CTN-0054 Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT) for Methamphetamine Use Disorder

NCT01982643 is registered in ClinicalTrials.gov with Walter Ling as lead sponsor.

NCT NCT01982643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01982643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CTN-0054 Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT) for Methamphetamine Use Disorder
Lead sponsor
Walter Ling
Phase
Phase 1/2
Overall status
Completed
Start date
November 30, 2013
Completion date
February 28, 2015
Enrollment
49 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

methamphetamine use disorder